Blocking Effect of Natural Alkaloids on COVID-19 Pentameric Ion Channel: An in silico Perspective

Biointerface Research in Applied Chemistry
2021.0

Abstract

Numerous deaths worldwide have been caused by the coronavirus pandemic and are currently progressing with successive mutations and a lack of appropriate and definitive treatment. One of the drug targets to control the replication of the virus and treat this disease is to block the ion channel of the virus. This will lead to its death by disturbing the internal balance of the virus. Natural compounds such as alkaloids are usually known as effective compounds due to their medicinal characteristics and easy access to their sources. To this end, more than 3,200 natural alkaloid structures interacted with pentameric ion channels. Alkaloid compounds established significant and stable interactions with the channel. More clearly and in more detail, six alkaloid compounds with the best pharmacokinetics and binding affinity of less than -10.52 kcal/mol were selected as hit and suitable compounds for viruscontrol. The compound of psammaplysin U (NA-1) with a binding affinity of -13.52 kcal/mol andbinding free energy of -82.21 kcal/mol established hydrogen interactions with the amino acid of Val 25 in the B chain of the ion channel, which placed the compound at the top of the selected compounds. The molecular dynamics simulation of the ligand-protein complex in the 100 ps trajectory showed that the principal interactions were hydrogen and halogen bonding with the amino acids of Val 25 and Thr 30 in the B chain and A chain, respectively, which could be a suitable inhibitor to combat the COVID-19.

Knowledge Graph

Similar Paper

Blocking Effect of Natural Alkaloids on COVID-19 Pentameric Ion Channel: An in silico Perspective
Biointerface Research in Applied Chemistry 2021.0
Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19)
Biomolecules 2021.0
Indole alkaloids as potential candidates against COVID-19: an in silico study
Journal of Molecular Modeling 2022.0
Potential of Natural Alkaloids From Jadwar (Delphinium denudatum) as Inhibitors Against Main Protease of COVID-19: A Molecular Modeling Approach
Frontiers in Molecular Biosciences 2022.0
Tetrandrine, an Effective Inhibitor of COVID-19 Main Protease (Mpro); Insights from Molecular Docking and Dynamics Simulations
International Journal of Pharmaceutical Investigation 2023.0
Quinoline and Quinazoline Alkaloids against COVID-19: An In Silico Multitarget Approach
Journal of Chemistry 2021.0
Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: anin silicoperspective
Antiviral Chemistry and Chemotherapy 2020.0
The Alkaloids of Isatis indigotica as Promising Candidates against COVID-19
Journal of Reports in Pharmaceutical Sciences 2022.0
In silico investigation of oxindole alkaloids from Uncaria perrottetii and Uncaria lanosa f. philippinensis for COVID-19 therapy: a ligand affinity and characterization study
Proceedings of the 12th International Conference on Biomedical Engineering and Technology 2022.0
Antimicrobial Alkaloids from Marine-Derived Fungi as Drug Leads versus COVID-19 Infection: A Computational Approach to Explore their Anti-COVID-19 Activity and ADMET Properties
Evidence-Based Complementary and Alternative Medicine 2022.0